Mitochondrial dysfunction in skin fibroblasts from a Parkinson's disease patient with an alpha-synuclein triplication

Journal of Parkinson's Disease

Volumn 1, Issue 2, 2011, Pages 175-183

  Mak, Sally K ^a   Tewari, Deepika ^a   Tetrud, James W ^a   Langston, J William ^a   Schüle, Birgitt ^a  

^a PARKINSON S INSTITUTE   (United States)

Author keywords

fibroblasts; mitochondrial dysfunction; Parkinson's disease; SNCA triplication

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA SYNUCLEIN; PARAQUAT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SMALL INTERFERING RNA;

ADULT; ALPHA SYNUCLEIN GENE; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; FEMALE; GENE FUNCTION; GENE IDENTIFICATION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MARKER GENE; MITOCHONDRIAL MEMBRANE POTENTIAL; MOLECULAR PATHOLOGY; OXIDATIVE STRESS; PARKINSON DISEASE; PARKINSONISM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; SKIN FIBROBLAST;

ADENOSINE TRIPHOSPHATE; ADULT; ALPHA-SYNUCLEIN; CELLS, CULTURED; ELECTRON TRANSPORT COMPLEX I; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; HERBICIDES; HUMANS; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MIDDLE AGED; MITOCHONDRIAL DISEASES; PARAQUAT; PARKINSON DISEASE; RNA, MESSENGER; RNA, SMALL INTERFERING; SKIN;

EID: 80054873779     PISSN: 18777171     EISSN: 1877718X     Source Type: Journal    
DOI: 10.3233/JPD-2011-11025     Document Type: Article

References (36)

1. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J & Gwinn-Hardy K (2003) alpha-Synuclein locus triplication causes Parkinson's disease. Scienc, 302, 841. (Pubitemid 37339619)
2. Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S, Levecque C, Larvor L, Andrieux J, Hulihan M, Waucquier N, Defebvre L, Amouyel P, Farrer M & Destee A (2004) alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet, 364, 1167-1169. (Pubitemid 39296604)
3. Devi L & Anandatheerthavarada HK (2010) Mitochondrial trafficking of APP and alpha synuclein: Relevance to mitochondrial dysfunction in Alzheimers and Parkinson's diseases. Biochim Biophys Acta, 1802, 11-19.
4. Devi L, Raghavendran V, Prabhu BM, Avadhani NG & Anandatheerthavarada HK (2008) Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem, 283, 9089-9100.
5. McFarland MA, Ellis CE, Markey SP&Nussbaum RL (2008) Proteomics analysis identifies phosphorylation-dependent alpha-synuclein protein interactions. Mol Cell Proteomics, 7, 2123-2137.
6. Chinta SJ, Mallajosyula JK, Rane A & Andersen JK (2010) Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo. Neurosci Lett, 486, 235-239.
7. Martin LJ, PanY, PriceAC, SterlingW, Copeland NG, Jenkins NA, Price DL & Lee MK (2006) Parkinson's disease alphasynuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J Neurosci, 26, 41-50. (Pubitemid 43089519)
8. Hsu LJ, Sagara Y, Arroyo A, Rockenstein E, Sisk A, Mallory M,Wong J, Takenouchi T, HashimotoM&Masliah E (2000) alpha-synuclein promotes mitochondrial deficit and oxidative stress. Am J Pathol, 157, 401-410. (Pubitemid 30627559)
9. Parihar MS, Parihar A, Fujita M, HashimotoM&Ghafourifar P (2008) Mitochondrial association of alpha-synuclein causes oxidative stress. Cell Mol Life Sci, 65, 1272-1284.
10. Parihar MS, Parihar A, Fujita M, Hashimoto M & Ghafourifar P (2009) Alpha-synuclein overexpression and aggregation exacerbates impairment of mitochondrial functions by augmenting oxidative stress in human neuroblastoma cells. Int J Biochem Cell Biol, 41, 2015-2024.
11. Shavali S, Brown-Borg HM, Ebadi M & Porter J (2008) Mitochondrial localization of alpha-synuclein protein in alpha-synuclein overexpressing cells. Neurosci Lett, 439, 125-128.
12. Li WW, Yang R, Guo JC, Ren HM, Zha XL, Cheng JS & Cai DF (2007) Localization of alpha-synuclein to mitochondria within midbrain of mice. Neuroreport, 18, 1543-1546. (Pubitemid 47476380)
13. Zuber TJ (2002) Punch biopsy of the skin. Am FamPhysician, 65, 1155-1158.
14. Huang SG (2002) Development of a high throughput screening assay for mitochondrial membrane potential in living cells. J Biomol Screen, 7, 383-389.
15. Grunewald A, Gegg ME, Taanman JW, King RH, Kock N, Klein C & Schapira AH (2009) Differential effects of PINK1 nonsense and missense mutations on mitochondrial function and morphology. Exp Neurol, 219, 266-273.
16. Mortiboys H, Thomas KJ, Koopman WJ, Klaffke S, Abou- Sleiman P, Olpin S, Wood NW, Willems PH, Smeitink JA, Cookson MR & Bandmann O (2008) Mitochondrial function and morphology are impaired in parkin-mutant fibroblasts. Ann Neurol, 64, 555-565.
17. Fountaine TM, Venda LL,Warrick N, Christian HC, Brundin P, Channon KM & Wade-Martins R (2008) The effect of alpha-synuclein knockdown on MPP+ toxicity in models of human neurons. Eur J Neurosci, 28, 2459-2473.
18. Bai RK, Perng CL, Hsu CH, Wong LJ (2004) Quantitative PCR analysis of mitochondrial DNA content in patients with mitochondrial disease. Ann N Y Acad Sci 1011, 304-309.
19. Waters CH & Miller CA (1994) Autosomal dominant Lewy body Parkinsonism in a four-generation family. Ann Neurol, 35, 59-64. (Pubitemid 24027607)
20. Schapira AH, Cooper JM, Dexter D, Jenner P, Clark JB & Marsden CD (1989) Mitochondrial complex I deficiency in Parkinson's disease. Lancet, 1, 1269. (Pubitemid 19140359)
21. Schapira AH (2008) Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol, 7, 97-109. (Pubitemid 350251942)
22. Henchcliffe C & Beal MF (2008) Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol, 4, 600-609.
23. Betarbet R, Sherer TB, Di Monte DA & Greenamyre JT (2002) Mechanistic approaches to Parkinson's disease pathogenesis. Brain Pathol, 12, 499-510. (Pubitemid 35154938)
24. Manning-Bog AB & Langston JW (2007) Model fusion, the next phase in developing animal models for Parkinson's disease. Neurotox Res, 11, 219-240.
25. Schapira AH, Cooper JM, Dexter D, Clark JB, Jenner P & Marsden CD (1990) Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem, 54, 823-827.
26. Parker WD, Jr, Parks JK & Swerdlow RH (2008) Complex I deficiency in Parkinson's disease frontal cortex. Brain Res, 1189, 215-218. (Pubitemid 351842538)
27. Haas RH, Nasirian F, Nakano K, Ward D, Pay M, Hill R & Shults CW (1995) Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease. Ann Neurol, 37, 714-722.
28. Blin O, Desnuelle C, Rascol O, Borg M, Peyro Saint Paul H, Azulay JP, Bille F, Figarella D, Coulom F & Pellissier JF et al. (1994) Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy. J Neurol Sci, 125, 95-101. (Pubitemid 24240194)
29. Hoepken HH, Gispert S, AzizovM, KlinkenbergM, Ricciardi F, Kurz A, Morales-Gordo B, Bonin M, Riess O, Gasser T, Kogel D, SteinmetzH& AuburgerG(2008) Parkinson patient fibroblasts show increased alpha-synuclein expression. Exp Neurol, 212, 307-313.
30. Yang W & Tiffany-Castiglioni E (2005) The bipyridyl herbicide paraquat produces oxidative stress-mediated toxicity in human neuroblastoma SH-SY5Y cells: Relevance to the dopaminergic pathogenesis. J Toxicol Environ Health A, 68, 1939-1961. (Pubitemid 41765788)
31. Yang W & Tiffany-Castiglioni E (2007) The bipyridyl herbicide paraquat induces proteasome dysfunction in human neuroblastoma SH-SY5Y cells. J Toxicol Environ Health A, 70, 1849-1857. (Pubitemid 47575097)
32. Yang W & Tiffany-Castiglioni E (2008) Paraquat-induced apoptosis in human neuroblastoma SH-SY5Y cells: Involvement of p53 and mitochondria. J Toxicol Environ Health A, 71, 289-299.
33. Gatto NM, Rhodes SL, Manthripragada AD, Bronstein J, Cockburn M, Farrer M & Ritz B (2010) alpha-Synuclein gene may interact with environmental factors in increasing risk of Parkinson's disease. Neuroepidemiology, 35, 191-195.
34. Manning-Bog AB, McCormack AL, Li J, Uversky VN, Fink AL & Di Monte DA (2002) The herbicide Paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein. J Biol Chem, 277, 1641-1644. (Pubitemid 34968732)
35. McCormack AL, Thiruchelvam M, Manning-Bog AB, Thiffault C, Langston JW, Cory-Slechta DA & Di Monte DA (2002) Environmental risk factors and Parkinson's disease: Selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol Dis, 10, 119-127. (Pubitemid 34775465)
36. Richardson JR, Quan Y, Sherer TB, Greenamyre JT &Miller GW (2005) Paraquat neurotoxicity is distinct from that of MPTP and rotenone. Toxicol Sci, 88, 193-201. (Pubitemid 41548761)